Objective: The aim of this study was to perform quantitative signal analysis of high-resolution body surface potential mapping (BSPM) recordings to assess its usefulness for the electrocardiographic characterization of patients with Brugada syndrome. The diagnostic value of the QRS integral and of the gradient of the ST segment have not been elucidated in Brugada syndrome. Methods: In 27 subjects (16 with Brugada syndrome and 11 healthy subjects), 120-lead BSPMs were recorded at baseline and after pharmacological provocation with intravenous administration of ajmaline (1 mg / kg). The recordings were analyzed for two regions outside the positions of the standard ECG leads: the right precordial leads (RPL) on the second and third intercostal space (high RPL) and the left precordial leads (LPL) between the fifth and seventh intercostal space (low LPL). Results: At baseline, in high RPL regions, patients with Brugada syndrome showed more positive QRS integrals (2568 vs. 21668 mV ms) and a steeper negative ST segment gradient (20.6260.41 vs. 20.2960.40 mV/ s) compared to healthy subjects, P,0.001. In contrast, in low LPL regions, reduced QRS integrals and positive ST segment gradients were observed. These ECG signs were even more pronounced after intravenous ajmaline and showed a better discrimination for patients with Brugada syndrome than differences in RPL or LPL during baseline, respectively. Conclusions: In the left precordial leads, patients with Brugada syndrome showed ECG changes which were reversed in relation to the ECG changes observed in right precordial leads. BSPM measurement is a useful tool to improve the understanding of the electrocardiographic changes in the Brugada syndrome.
Characteristic ECG signs of the Brugada syndrome may with survived cardiac arrest due to ventricular fibrillation be mild and highly variable over time. Therefore, the who had characteristic ECG features (atypical right bundle identification of high-risk patients may be difficult because branch block (RBBB) and right precordial ST elevation) of borderline findings or transient ECG changes. However, but no structural heart disease. This entity was later family members of index patients and asymptomatic referred to as 'Brugada syndrome Therefore, improvement of noninvasive electrocar-2.2. Body surface potential mapping diographic detection of Brugada syndrome is desirable. We hypothesized that: (1) BSPM may identify atypical ECG Electrodes were applied to the chest in vertical strips lead positions that might be superior to the conventional (Fig. 1) ; each electrode (Foxmed, Idstein, Germany) had a ECG in diagnosing patients with Brugada syndrome; (2) 10-mm diameter Ag /AgCl sensor embedded in an epoxy reversal of changes of the typical ECG signs should occur housing with a 2-mm gel cavity. In vertical direction, the in an opposite area of the torso; and (3) provocation with inter-electrode distance on the strips were 50 mm. The 120 intravenous sodium channel blockers may improve the unipolar ECG leads referred to Wilson central terminal and diagnostic value of these BSPM characteristics in patients were recorded simultaneously [10] . The ECG signals were with Brugada syndrome. During the course of our study, amplified, bandpass-filtered (0.16-400 Hz) and A / D conShimizu et al. [7] used BSPM measurements to show that verted to 16-bit samples (0.5 mV least significant bit) using the ST segment elevation 20 ms after the end of QRS was a sampling rate of 1 kHz (Mark-6, Biosemi, Amsterdam, located at the parasternal second and third intercostal space The Netherlands). Leads which were excessively noisy or which allowed a better identification of the characteristic which contained artifacts were excluded from the data set ECG signs in Brugada syndrome.
for further off-line analysis. Measurements started at The present study therefore assessed the presence of resting conditions (5 min) and continued during ajmaline typical ECG signs of the Brugada syndrome in 120-infusion (1 mg / kg; 10 mg / min) and 4-8 min after channel ECG recordings (BSPM) at baseline and during infusion of ajmaline. intravenous ajmaline with particular focus on high right precordial (high RPL) and low left precordial lead (low 2.3. Drug administration LPL) areas. While Shimizu et al.
[7] studied a single ST segment instantaneously potential distribution the two
The sodium channel blocker ajmaline was administered novel ECG parameters provide additional information:
intravenously at a constant rate of 10 mg / min until a total QRS integral relates to activation, whereas ST segment dose of 1 mg / kg was reached. Drug administration was gradient relates to the rate of potential change during early stopped, if QRS duration increased more than 20% comrepolarisation. These new ECG parameters were analysed pared to baseline or in case of the occurrence of complex from BSPM recordings with respect to their diagnostic ventricular arrhythmias. value in patients with Brugada syndrome.
2.4. Genotyping
Methods
We performed SSCP analysis of the entire coding regions of the cardiac sodium channel gene SCN5A in all 2.1. Patient selection patients listed in Table 1 and used previously published primer for PCR [11] . SSCP analysis was improved by the Patients with Brugada syndrome (n516) were prospecuse of two fluorescence-labelled primers and by optimized tively screened. The diagnosis of Brugada syndrome was running and temperature conditions during electrophoresis made on the basis of typical ECG features (persistent or on an ALF DNA sequencer (Amersham-Pharmacia, transient right precordial ST segment elevation with or Freiburg, Germany). Only aberrant SSCP conformers were without atypical right bundle branch block), clinical arfollowed by direct sequencing (BDT kit together with ABI rhythmic events (syncope, ventricular fibrillation, cardiac 3700; Perkin-Elmer, Norfolk, USA). arrest), family history, and the absence of identifiable structural heart disease. Detailed noninvasive and invasive 2.5. Signal analysis investigations included two-dimensional echocardiography, left and right ventricular angiography, coronary angiogSignal analysis was performed offline for recordings at raphy, magnetic resonance imaging, and endomyocardial baseline and at the maximum ajmaline dose (1 mg / kg). In biopsy.
a selected single beat with good signal to noise ratio and All patients underwent an invasive electrophysiological no offset variation due to respiratory motion, QRS onset, examination with programmed ventricular stimulation with QRS offset and T onset were determined visually from the up to three extrastimuli as previously reported [8] . During superimposed Goldberger aVR, aVL and aVF leads. For BSPM measurement, patients were in stable sinus rhythm.
each BSPM lead the amplitude offset was corrected by the Pharmacological provocation with intravenous ajmaline (1 mean amplitude level of a 20-ms reference window located mg / kg, 10 mg / min) was performed to unmask or intensify in the PQ interval of the ECG (Fig. 2) . The mean ECG signs of Brugada syndrome [9] . Written informed amplitude level is the offset potential value of the differenconsent was obtained from all patients who entered the tial amplifier which has to be subtracted as reference value. study. The investigation conforms with the Declaration of
The interval of 20 ms is selected for the time window to Helsinki.
avoid 50-Hz line interference in the reference potential value (the average is over one period, 20 ms, of the line defined by the earliest T-wave onset of the limb leads, interference interval). For each surface lead, the QRS respectively. The gradient of this 'true ST segment' was integral was calculated. The beginning of the ST segment calculated as the slope of the best linear fit of this sample. was defined by the latest QRS offset determined in the Fig. 2 also illustrates that R9 peaks that appear in case of superimposed limb leads. The end of the ST segment was an atypical RBBB were not taken into account for the explained syncope (n54), one patient had both. The remaining four patients were asymptomatic and presented with a family history of unexplained cardiac arrest or syncope. In the four asymptomatic patients, typical ECG abnormalities indicating Brugada syndrome were found during routine ECG examination. Eight patients had a positive family history, whereas the remaining eight patients had no family members with cardiac arrest or unexplained syncope.
Control group
The age-matched control group consisted of 11 subjects (mean age 53612, range 36-69; P5NS versus study patients) without structural heart disease, with normal BSPM lead was adjusted using a reference segment in the PQ segment of the ECG. The right precordial lead of patient with Brugada syndrome showed a typical R9 peak inside the QRS complex.
QRS integral and the gradient of the ST segment in BSPM and V1 -V6
analysis of the ST segment; thus, the steep gradient
The BSPM recordings showed the characteristic ECG following the point of maximum R9 amplitude was not pattern of Brugada syndrome. An example of a BSPM included.
recording of a Brugada patient is given in Fig. 3a . The We assessed ECG variations in QRS integral and ST variations were even more pronounced after intravenous segment gradient of BSPM recordings and compared the administration of ajmaline (Fig. 3b) . Especially in the high results to findings from the standard unipolar precordial right precordial leads, the typical pattern of elevated R9-leads V1 to V6. peaks were found followed by negative gradients of the ST segment into negative T-waves; reverse changes of this 2.6. Statistics pattern were observed in the low left precordial leads.
After a positive Kruskal-Wallis H-test, the nonparametric Mann-Whitney U-test was used to compare the results 3.3.1. Measurements at baseline of recordings from Brugada patients and healthy subjects.
Typical ECG signs of the Brugada syndrome were For each patient, mean values of the QRS integrals and ST observed in right precordial leads and were more proslopes were calculated from the four leads of both, the high nounced on the higher right torso (second and third RPL and the low LPL areas. A level of P , 0.05 was intercostal space). Although there is a variability in the considered to represent significant differences between the QRS integral maps of normal subjects [12] , the spatial groups. The Wilcoxon test was used to identify changes distribution of the QRS integrals showed marked changes during intravenous ajmaline. compared to control (Fig. 4a,b) . The results of the quantitative signal analyses are summarized in Table 2 . Under resting conditions, the high RPL area showed 3. Results increased QRS integrals (2568 vs. 21668 mV ms) and more negative ST slopes (20.6260.41 vs. 20.2960.40 3.1. Study patients mV/ s) compared to control (P,0.001 each, Fig. 5 ). In contrast, the QRS integrals and ST segment gradients Sixteen patients (10 men, six women; age 49612 years, measured in the standard ECG leads V1-V3 were not range 28-66 years) with Brugada syndrome were investistatistically different between Brugada and control pagated. The clinical characteristics of the study patients are tients. summarized in Table 1 . Written informed consent was
In the low LPL leads, reverse changes of the signal obtained from all patients who entered the study. characteristics were identified. This resulted in lower QRS All patients had characteristic ECG signs of Brugada integrals (12610 vs. 23615 mV ms) and higher ST slopes syndrome with atypical right bundle branch block (QRS (0.7560.44 vs. 0.3160.32 mV/ s) as compared to the prolongation) and ST segment elevation. Twelve patients control group (P,0.001 each). In the standard left precorhad a history of survived cardiac arrest (n59) or undial ECG lead V5, the ST segment gradient was increased each). Fig. 3c shows an example of the typical ST segment 23613 mV ms) and an increase in ST segment gradients gradients found in Brugada patients at baseline. 
Measurements after intravenous ajmaline increase in the QRS integrals (23622 mV ms, P,0.05) The spatial distribution of the QRS integrals after
and a decrease in ST segment gradients (22.1264.92 administration of ajmaline showed no apparent changes mV/ s, P,0.05) (Fig. 5 ). compared to measurements at baseline (Fig. 4c) . However, In the low LPL leads, even more decreased QRS the Brugada syndrome-typical ECG characteristics in the integrals (5613 mV ms, P,0.001) and more positive ST low LPL and high RPL areas were even more pronounced slopes (1.7461.28 mV/ s, P,0.001) were observed. For during provocation with the sodium channel blocker the standard left precordial ECG leads V4-V6, a signifiajmaline (Wilcoxon test, P,0.05), except for the QRS cant decrease in QRS integrals (23621 vs. 18618 mV ms integral in the low LPL area (P50.083). During intravenin control subjects at baseline, P,0.05) and an increase in ous ajmaline, the high RPL area showed more increased ST segment gradients (2.8962.54 vs. 0.9860.76 mV/ s, QRS integrals (1610 mV ms) and more decreased ST P,0.05) were found in V4. In V5, a decrease in QRS segment gradients (21.8061.93 mV/ s) compared to conintegrals (7614 vs. 27620 mV ms, P,0.05) and an trol subjects at baseline (P,0.001 each). In the standard increase in ST segment gradients (2.0361.69 vs. right precordial ECG leads V1-V3, only V1 showed an 0.4760.29 mV/ s, P,0.001) were measured. In addition, Mean6S.D., *P,0.05 and †P,0.001 compared to control group. High RPL, mean of the right precordial BSPM leads on second to third intercostal space; low LPL, mean of the left precordial BSPM leads between fifth and seventh intercostal space; V1-V6, precordial leads obtained from 12-channel standard ECG. of independent families were 13. In one (female) of 13 index patients (8%), we identified a heterozygous mutation in exon 16 of the SCN5A gene that is predicted to truncate the channel protein and most likely leads to a nonfunctional channel subunit. The mutation could be followed within the family and causes a variable ECG phenotype (unpublished data).
In the other 12 index patients, aberrant SSCP conformers were shown to result from various SNPs in SCN5A and, since present in a control population, not further considered to be causative for Brugada syndrome. Here, the genetic basis for the disease remains to be determined.
The patient with mutation in the SCN5A gene showed typical ST elevation in the right precordial leads V1-V3, which were even more pronounced after ajmaline infusion and degenerated from saddle-type to coved-type morphology. The measured novel BSPM characteristics were close to the median of the total group of patients with Brugada syndrome studied and showed no systematic differences.
Discussion
Body surface potential mapping (BSPM) is superior to 12-lead standard ECG in diagnosing ECG phenomena because of several reasons: first it is superior by recording 120 unipolar electrograms from the entire torso surface, thus the representation of an altered cardiac activation on the body surface is therefore not limited to the standard lead positions. In addition, the high amplitude resolution and advanced techniques for signal analysis enable a detailed assessment of ECG phenomena manifesting in the ST segment and T wave of the ECG.
In patients with Brugada syndrome, BSPM measurements with and without intravenous ajmaline and signal analysis of the QRS complex and ST segment demonstrated new ECG characteristics, which may enable improved diagnosis of Brugada syndrome. [6]. To improve the sensitivity of the ECG, in the present study, a quantitative signal analysis of BSPM recordings in V6 a decrease in QRS integrals (8610 vs. 23613 mV revealed additional ECG characteristics, which reflect the ms, P,0.05) and an increase in ST segment gradients Brugada-like variation of the surface ECG. In accordance (1.5361.14 vs. 0.3160.18 mV/ s, P,0.001) were obwith the findings of Shimizu et al. [7] , BSPM measureserved.
ments identified more pronounced ECG variations in the right precordial leads placed on the second and third 3.4. Genotyping intercostal space. In addition, the high RPL region presented with a characteristic elevation of R9 waves and, Fourteen of 15 patients were investigated by SSCP, therefore, resulted in more positive QRS integrals comhereunder two related family members. Thus, the number pared to control subjects. Even under baseline conditions, steep negative gradients of the ST segment were observed genotype-phenotype correlation with BSPM parameters in this area. By analysing the QRS integrals and ST has not been performed yet. segment gradients, the high RPL and the low LPL areas The propensity to syncope or sudden cardiac death in were the best separating areas to identify patients with asymptomatic patients with Brugada syndrome is difficult Brugada syndrome. These areas do not include the right to estimate. During a follow-up period of 34 months, precordial leads conventionally used for the diagnosis of event-rates between 0 [6] and 27% [18] were reported. Brugada syndrome. In addition, for the most part they are Absence of symptoms is not a reliable predictor for outside the standard leads V1-V6. For the electrocarfreedom from future events and is therefore of limited diographic characterization of patients with Brugada value for risk stratification in the individual patient. Since syndrome, previous studies focused on the standard right the accuracy of programmed electrical stimulation in precordial leads V1-V3. In contrast, in our study additional predicting patients at risk may also be limited, BSPM alterations of signal characteristics were found in V4-V6 measurement is a useful tool to improve the electroand in the low LPL area. Compared to control subjects, we cardiographic understanding of the Brugada syndrome and identified a significant decrease of the integrals in the QRS to improve the ECG criteria for reliable individual risk complex and significantly increased positive ST segment, stratification. which may reflect a reversal of the typical ECG findings in the right precordial leads of patients with the Brugada syndrome. ECG changes identified by signal analysis of
